FDA Delays Covid Therapeutics | December 17, 2021

Morning Wire

The Daily Wire

Daily News, News

4.9 • 25.6K Ratings

🗓️ 17 December 2021

⏱️ 14 minutes

🔗️ Recording | iTunes | RSS

🧾️ Download transcript

Summary

FDA delays approval for Covid therapeutics, backlash builds in California over rising crime, and Congress votes on a measure to protect Uyghurs in China. Get the facts first on Morning Wire.

Transcript

Click on a timestamp to play from that location

0:00.0	Fizer's new COVID pill reduced deaths by nearly 100% in clinical trials, yet the FDA still
0:09.7	hasn't scheduled a meeting to review the medication.
0:12.4	It's remarkable and game-changing for the whole pandemic yet, the FDA has been sitting
0:17.1	on this application now.
0:19.0	It's a disgrace.
0:20.0	What's behind the delay and why aren't we hearing more about these lifesaving treatments?
0:24.4	I'm John Bickley with Georgia Hale.
0:27.2	It's Friday, December 17th, and this is Morning Wire.
0:29.9	District's attorneys in Los Angeles and San Francisco are facing recalls due to rising
0:38.0	crime.
0:39.0	Our California residents finally sowering on soft-down crime policies.
0:43.7	And after much debate, Congress passes legislation that bans the import of any goods made with
0:48.3	forced labor from weaker Muslims.
0:50.8	What impact will the bill have and who was trying to stop it?
0:54.2	Thanks for waking up the Morning Wire.
0:55.8	Stay tuned.
0:56.8	Newspapers and news you need to know.
1:22.6	New oral medications for treating COVID-19 have shown spectacular results in clinical
1:27.7	trials.
1:28.7	Yet, despite surging cases, these lifesaving treatments still aren't being prescribed
1:33.2	here in the US.
1:35.0	Here to discuss is Johns Hopkins, Dr. Marty McCary.
	...

Please login to see the full transcript.

Previous episode | Next episode

Disclaimer: The podcast and artwork embedded on this page are from The Daily Wire, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of The Daily Wire and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.